Abstract

Advances in cancer prevention, screening and early detection, diagnosis, treatment, and care delivery have yielded significant improvements in survival for cancer patients and decreases in cancer-related treatment toxicity. However, these advances have been accompanied by an increasing financial burden to patient and their caregivers. Financial toxicity, which draws a parallel between the side effects of cancer treatment and the side effects of undue financial distress, is increasingly recognized as being common and a source of significant morbidity and decreased health-related quality of life for head and neck cancer (HNC) patients and their caregivers. This chapter will (1) define financial toxicity following cancer treatment, (2) estimate its incidence in HNC patients, (3) highlight key risk factors in HNC patients, (4) describe various tools for its measurement, (5) discuss the impact of financial toxicity on HNC patients, and (6) review resources on financial toxicity for patients and caregivers. Knowledge gaps and research opportunities to improve the delivery of patient-centered cancer care that is attentive to the complex issue of financial toxicity will be explored at the conclusion.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.